In the not too distant past Alzheimer's disease was considered sufficiently ubiquitous to permit its diagnosis in the elderly demented, once cerebrovascular disease, cerebral trauma and alcohol abuse had been excluded. An attempt to use inclusion rather than exclusion criteria for "probable" or "possible" Alzheimer's disease is contained in the Diagnostic Statistical Manual III. The latter now serves as holy writ in the search for clinical confirmation of Alzheimer's disease to the neglect of forms of cerebral atrophy which may be clinically and pathologically distinct from Alzheimer's disease and yet meet its descriptive psychiatric diagnostic criteria.
The last few years have witnessed a directional change in the investigation of primary cerebral atrophy with qualitative neuropsychological analysis of clinical syndromes allied to more functional brain imaging techniques and histological verification. Some new and distinct cerebral disorders have emerged, which are much more common than previously supposed and those reviewed here comprise dementia frontal-lobe type (DFT), DFT and motor neuron disease (MND), lobar atrophy and diffuse Lewy body disease. Dementia of frontal-lobe type and motor neuron disease In general patients with DFT survive for many years and some have survived for over fifteen years from onset. However, four patients have been described,7 in whom a profound and rapidly progressive dementia occurred in association with clinical features of motor neuron disease. Mental changes occurred first and the pattern of dementia indicated impaired frontal lobe function, confirmed by reduced tracer uptake in the frontal lobes on single photon emission computerised tomography (SPECT). Later weakness, wasting and fasciculations of limb muscles emerged and progressive bulbar palsy led to death within two years of onset. Electrophysiological studies confirmed widespread muscular denervation compatible with motor neuron disease.
Pathological examination of the brains of three patients revealed fronto-temporal lobe atrophy, with loss of large pyramidal neurons, mild gliosis and spongiform change. Similar changes were found in the corpus striatum and thalamus and also there was significant cell loss and gliosis in the substantia nigra. Depletion of neurons in the hypoglossal nuclei and anterior horns of the spinal cord, was not accompanied by significant changes in the cortico-bulbar and cortico-spinal tracts. The pathological findings mirror closely those of Japanese patients with dementia and motor neuron disease.8
Previous studies have failed to define the precise clinical characteristics of the associated dementia. However in this most recent study both the clinical picture and pathological findings resembled those of DFT and were distinct from those of Alzheimer's disease.
It is clear that the high familial incidence of DFT demands further cytogenetic studies to shed light on the associated motor neuron disease and other forms of primary degenerative dementia.
Lobar atrophy Awareness of DFT and other cerebral degenerations with non-Alzheimer's pathology such as the syndrome of slowly progressive aphasia,9 10 ought to awaken investigators to the possibility of additional forms of focal atrophy. Slowly progressive aphasia first described by Wechsler The relatively large number of cases of progressive aphasia in the literature, presumably reflects the vulnerability of language functions to cerebral disease and it is predicted that selective neuropsychological deficits will be associated with focal degenerations in the right cerebral hemisphere. Pathological evidence will be required to bring unity to increasing numbers of clinically based observations.
Benson et al 22 have described the clinical syndrome of "posterior cortical atrophy" which is likely to represent lobar atrophy of the parieto-occipital cortex. Five patients presented with early and severe ataxia, agraphia, acalculia, anomia, visual agnosia and disorientation, disorders of ocular fixation and a transcortical sensory aphasia. Memory, insight and personal conduct were strikingly preserved and the neurological examination was normal. Computerised tomography and magnetic resonance imaging revealed cerebral atrophy most marked in the posterior hemispheres. Pathological verification indicates nonAlzheimer's disease in some cases and in others, forms of Alzheimer's disease in which the pathological changes appear preferentially to affect the parietal occipital association cortex in the early stages of progression.
A case has been described of progressive apraxia in the absence of any other neuropsychological deficits23 and atrophy localised to the superior parietal lobules has been demonstrated on SPECT. Progressive apraxia has also been described in association with apperceptive visual agnosia.24 Unfortunately, pathological characterisation was lacking from these case descriptions.
Lewy body disease Japanese investigators described the syndrome ofdementia and rigidity in which Lewy bodies occurred in mid-line nuclei with or without cortical neuro-fibrillary tangles and senile plaques.2526 Unfortunately, clinical psychological descriptions were meagre. Interest in "Lewy body disease" was kindled by a description of patients initially thought to have Parkinson's disease because of akinesia and rigidity but who had striking and early fluctuating mental changes of a sub-acute confusional state with behavioural disorder and hallucinations. Necropsy revealed Lewy bodies not only in the substantia nigra but widespread throughout the cerebral cortex. 27 The Nottingham group went on to demonstrate the superiority of anti-ubiquitin immunocytochemistry over conventional techniques in the detection of diffuse Lewy bodies.28 Utilising the technique, they described the clinical and pathological features of fifteen cases of diffuse Lewy body disease.29 '3 Fifteen brains with the pathological hallmarks of diffuse Lewy body disease had been collected in one centre in one year. The patients had been longitudinally studied, neurologically and psychologically with sufficient cognitive measures to permit the rating of severity of dementia on a five point scale. Of equal incidence were patients who had presented with Parkinson's disease and later developed dementia, and patients who had presented with dementia and who later developed Parkinson's disease. The form of Parkinson's disease was indistinguishable from idiopathic Nrkinson's disease and the motor symptoms were responsive to levodopa. The dementia was "cortical" in type with amnesia, aphasia, visuo-spatial disorientation and apraxia running a fluctuating course and complicated by hallucinations, agitation and confusion.
Pathologically, Lewy bodies were identified profusely in the cerebral cortex and their numbers were highly correlated with the severity of dementia. There was neuronal loss in the substantia nigra with Lewy bodies in the surviving neurons, but there was no correlation with these sub-cortical changes and the severity ofdementia. This was true for similar changes in the nucleus basalis. Of considerable interest was the presence of large numbers of cortical senile plaques, the density ofwhich correlated with. It is evident from a survey of recent investigations into dementia that not all primary cerebral atrophy represents Alzheimer's disease and it is likely that fresh clinical pathological designations will proliferate. Such progress will be made by adopting neuropsychological analytical techniques whkth specifiy the qualitative nature of clinical syndromes rather than submerging differences under a weight of numbers generated by standard clinical psychological battery tests. The quantification and rating of the severity of dementia should follow the specification of the dementia syndrome. Distinct neurological syndromes can now be evaluated in life using functional imaging such as SPECT and PET which are capable of generating topographical cerebral correlates of behaviour. The pathological evaluation of brains, using morphometric histological analyses and the new dynamic techniques is bound to be most informative when correlated with quantitative neuropsychological measures made during life.
Principally, conceptual progress is likely to be furthered by rejecting the notion that dementia represents a nonspecific breakdown in intellect and memory, rather than distinct neuropsychological syndromes characterising particular cerebral disorders and their pathological and functional differentiation within the brain. 
